Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Carbamazepine Prices, Demand and Supply Overview
Carbamazepine prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 54.9/KG in Q1 to USD 58.2/KG by Q2 as recovering epilepsy, trigeminal neuralgia, and bipolar disorder formulation procurement and firmer iminodibenzyl synthesis intermediate costs reversed the brief Q4 2025 market correction. Globally, the average rose from USD 39.14/KG in Q1 to USD 41.49/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 40.3-45.3/KG is expected, with continued firming on Middle East supply disruptions and growing anticonvulsant, trigeminal neuralgia, and bipolar mood stabiliser sector demand globally.
Carbamazepine is a dibenzazepine anticonvulsant and mood stabiliser produced by multi-step synthesis from iminodibenzyl precursor through N-chlorocarbonyl ring closure or reaction with cyanogen bromide to yield the 5H-dibenz[b,f]azepine-5-carboxamide active pharmaceutical ingredient. The compound inhibits neuronal firing by use-dependent and voltage-dependent blockade of voltage-gated sodium channels, stabilising inactivated channel conformations and reducing high-frequency repetitive discharge in epileptic neuronal circuits and in ectopic trigeminal sensory nucleus firing driving trigeminal neuralgia pain. The largest pull comes from epilepsy pharmacotherapy, where carbamazepine remains a first-line option in national treatment guidelines for focal partial seizures and continues as a low-cost generic in essential medicine programmes globally. Trigeminal neuralgia first-line therapy and bipolar type I manic episode and maintenance mood stabilisation add significant further demand. Neuropathic pain management in diabetic peripheral neuropathy and postherpetic neuralgia, essential medicine programme supply chains including low-cost generic carbamazepine tablet formulation, and supervised alcohol withdrawal seizure prevention add consistent further volumes. Iminodibenzyl synthesis costs, epilepsy and trigeminal neuralgia prescription volumes, and regional API production capacity all feed into the price.
Carbamazepine Price Forecast for 2026
The balance of supply and demand for Carbamazepine through H2 2026 leans moderately firm. Iminodibenzyl synthesis intermediate costs firmed from Middle East chemical supply disruptions. Epilepsy, trigeminal neuralgia, and bipolar disorder demand are growing with expanding neurological treatment access globally.
The main upside risk is synthesis intermediate cost increases alongside accelerating essential medicine programme procurement. The main downside risk is oxcarbazepine and newer-generation antiepileptic prescribing preference and Chinese and Indian API surplus maintaining price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 40.3 - 45.3 | Synthesis cost firming and epilepsy/neuralgia/bipolar demand |
| United States | 43.0 - 48.0 | Steady epilepsy and trigeminal neuralgia demand holds firm |
| China | 29.9 - 34.9 | Large API capacity keeps it the most affordable |
| Germany | 53.5 - 58.5 | High synthesis and energy costs keep it the most expensive |
| India | 41.3 - 46.3 | Growing anticonvulsant and export demand holds a firm middle |
For the Quarter Ending June 2026
Carbamazepine Prices Q2 2026:
- United States: USD 47.2/KG
- China: USD 32.6/KG
- Germany: USD 58.2/KG
- India: USD 44.9/KG
Carbamazepine Prices in the United States
US Carbamazepine prices averaged USD 47.2/KG in Q2 2026, up 6.1% from USD 44.5/KG in Q1 2026. Firmer synthesis intermediate costs and recovering epilepsy and trigeminal neuralgia procurement drove consistent buying through the quarter.
Why did the price of Carbamazepine change in Q2 2026 in the United States?
Firmer iminodibenzyl synthesis intermediate costs raised the API production floor. Epilepsy focal seizure, trigeminal neuralgia, and bipolar disorder formulation procurement lifted buying. Neuropathic pain and essential medicine programme demand provided additional support near USD 47.2/KG.
Carbamazepine Prices in China
Chinese Carbamazepine prices averaged USD 32.6/KG in Q2 2026, up 5.8% from USD 30.8/KG in Q1 2026, the lowest among the tracked markets. Spring epilepsy and neuralgia export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite large domestic API capacity.
Why did the price of Carbamazepine change in Q2 2026 in China?
Spring epilepsy and trigeminal neuralgia export and domestic procurement lifted buying. Firmer domestic iminodibenzyl synthesis costs raised the production floor. Large domestic API capacity kept China the most affordable source.
Carbamazepine Prices in Germany
German Carbamazepine prices averaged USD 58.2/KG in Q2 2026, up 6.0% from USD 54.9/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering epilepsy, trigeminal neuralgia, and bipolar demand maintained buying.
Why did the price of Carbamazepine change in Q2 2026 in Germany?
Higher iminodibenzyl synthesis intermediate and energy costs elevated European production economics. Middle East supply disruptions added cost premiums. Recovering epilepsy, trigeminal neuralgia, and bipolar formulation procurement maintained buying near USD 58.2/KG.
Carbamazepine Prices in India
Indian Carbamazepine prices averaged USD 44.9/KG in Q2 2026, up 5.9% from USD 42.4/KG in Q1 2026. Growing epilepsy, trigeminal neuralgia, and anticonvulsant export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Carbamazepine change in Q2 2026 in India?
Growing epilepsy and trigeminal neuralgia export and domestic procurement lifted buying. Firmer synthesis import costs raised the production floor. Bipolar disorder and essential medicine export demand provided additional support near USD 44.9/KG.
For the Quarter Ending March 2026
Carbamazepine Prices Q1 2026:
- United States: USD 44.5/KG
- China: USD 30.8/KG
- Germany: USD 54.9/KG
- India: USD 42.4/KG
Carbamazepine Prices in the United States
US prices averaged USD 44.5/KG in Q1 2026, recovering about 2.1% from Q4 2025. Recovering epilepsy and neuralgia demand and firming synthesis costs held the market near USD 44.5/KG.
Why did the price of Carbamazepine change in Q1 2026 in the United States?
Recovering epilepsy and trigeminal neuralgia procurement maintained buying. Firming iminodibenzyl synthesis costs raised the production floor. The market recovered to USD 44.5/KG from the Q4 2025 correction.
Carbamazepine Prices in China
Chinese prices averaged USD 30.8/KG in Q1 2026, recovering about 2.0% from Q4 2025. Post-Lunar New Year epilepsy and neuralgia restocking and firmer synthesis costs held the market near USD 30.8/KG.
Why did the price of Carbamazepine change in Q1 2026 in China?
Post-Lunar New Year epilepsy and neuralgia restocking lifted buying. Firming domestic synthesis costs raised the floor. The market recovered to USD 30.8/KG from the Q4 2025 dip.
Carbamazepine Prices in Germany
German prices averaged USD 54.9/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering epilepsy and trigeminal neuralgia demand and firming synthesis and energy costs held the market near USD 54.9/KG.
Why did the price of Carbamazepine change in Q1 2026 in Germany?
Recovering epilepsy, trigeminal neuralgia, and bipolar procurement maintained buying. Firming synthesis and energy costs raised the production floor. The market recovered to USD 54.9/KG from the Q4 2025 correction.
Carbamazepine Prices in India
Indian prices averaged USD 42.4/KG in Q1 2026, recovering about 1.9% from Q4 2025. Growing epilepsy and neuralgia demand and firmer synthesis import costs held the market near USD 42.4/KG.
Why did the price of Carbamazepine change in Q1 2026 in India?
Growing epilepsy and trigeminal neuralgia procurement maintained buying. Firming synthesis import costs raised the floor. The market recovered to USD 42.4/KG from the Q4 2025 correction.
Quarterly Carbamazepine Price Trends
Global Carbamazepine prices rose in Q3 2025 on the anticonvulsant and neuralgia prescription season, dipped in Q4 2025 on synthesis cost moderation, then recovered through Q1 and Q2 2026. The average rose from USD 38.0/KG in Q2 2025 to USD 38.76/KG in Q3, eased to USD 38.37/KG in Q4, then firmed to USD 39.14/KG in Q1 2026 and USD 41.49/KG in Q2 2026, a net gain of about 9.2% over the window. Iminodibenzyl synthesis cost cycles and epilepsy, trigeminal neuralgia, and bipolar procurement drove the overall pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 41.49 | +6.0% | ↑ Rising |
| Q1 2026 | 39.14 | +2.0% | ↑ Rising |
| Q4 2025 | 38.37 | -1.0% | ↓ Falling |
| Q3 2025 | 38.76 | +2.0% | ↑ Rising |
| Q2 2025 | 38.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
What was Carbamazepine Price in 2025?
Carbamazepine prices firmed modestly through 2025 on consistent epilepsy and trigeminal neuralgia demand. The global average opened near USD 36.8/KG in Q1 2025 and closed at USD 38.37/KG in Q4, a full-year gain of about 4.3%. Synthesis cost dynamics and epilepsy, neuralgia, and bipolar procurement drove the pattern throughout the year.
Carbamazepine Prices in the United States in 2025
US prices firmed from about USD 42.1/KG in Q1 2025 to USD 43.6/KG by Q4, a gain of 3.6%. Consistent epilepsy and trigeminal neuralgia demand maintained the upward trend.
Carbamazepine Prices in China in 2025
Chinese prices firmed from roughly USD 29.2/KG in Q1 2025 to USD 30.2/KG by Q4, a gain of 3.4%. Growing anticonvulsant export and domestic demand drove moderate firming.
Carbamazepine Prices in Germany in 2025
German prices firmed from about USD 52.1/KG in Q1 2025 to USD 53.8/KG by Q4, a gain of 3.3%. Consistent epilepsy and trigeminal neuralgia demand and firm synthesis costs supported the market.
Carbamazepine Prices in India in 2025
Indian prices firmed from roughly USD 40.3/KG in Q1 2025 to USD 41.6/KG by Q4, a gain of 3.2%. Growing anticonvulsant and essential medicine export demand drove consistent firming.
How We Can Help
Expert Market Research: Your Source for Real-Time Carbamazepine Price Intelligence
Expert Market Research tracks Carbamazepine prices continuously across every major producing and consuming region. The team traces causation through iminodibenzyl synthesis intermediate economics, epilepsy and trigeminal neuralgia prescription cycles, and regional API production capacity. Contact Expert Market Research today for Carbamazepine pricing data, bespoke market analysis, and strategic procurement advisory.
Pricing Plans
Upto 15% Off
USD
-
$799 $699
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Key Questions Answered in the Report
Epilepsy pharmacotherapy as a first-line option for focal partial seizures and secondarily generalised tonic-clonic seizures in national treatment guidelines and essential medicine programmes takes the largest share. Trigeminal neuralgia as the designated first-line therapy for paroxysmal facial pain, bipolar type I manic episode and maintenance mood stabilisation, and neuropathic pain also consume significant volumes globally.
The Q2 2026 average was USD 47.2/KG in the United States, USD 32.6/KG in China, USD 58.2/KG in Germany, and USD 44.9/KG in India. Germany remains the highest-priced market.
The global average rose from USD 39.14/KG in Q1 to about USD 41.49/KG in Q2, a gain of around 6.0%. Recovering epilepsy and trigeminal neuralgia demand and firmer synthesis intermediate costs drove the H1 firming from the Q4 2025 correction.
Iminodibenzyl synthesis intermediate cost moderation eased the API production floor. Post-summer anticonvulsant and neuralgia procurement moderation reduced urgency before the H1 2026 recovery.
The global average is expected in the USD 40.3 to 45.3/KG range for H2 2026, with continued firming as synthesis costs stay elevated and epilepsy, neuralgia, and bipolar demand grows.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on epilepsy and neuralgia demand, and China prices lowest on domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to iminodibenzyl synthesis intermediate costs, epilepsy and trigeminal neuralgia prescribing volumes, and bipolar disorder treatment access expansion. Synthesis precursor prices and neurology prescribing data are key signals.
China and India hold the largest carbamazepine API synthesis capacity. Any iminodibenzyl synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time epilepsy and neuralgia formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor epilepsy and trigeminal neuralgia prescribing as demand signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
- Report in Excel Format
- 3 Months Price Forecast
- Historical Prices for the Past 3 Years
-
Summary Of Factors Influencing Prices
- Current Price Overview
- 3-Month Price Forecast
- Historical Price Summary
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.